Ductal lavage
Showing 1 - 25 of 954
Acinar Cell Carcinoma, Ampulla of Vater Adenocarcinoma, Cholangiocarcinoma Trial in Cleveland, Philadelphia (Pancreatectomy,
Recruiting
- Acinar Cell Carcinoma
- +7 more
- Pancreatectomy
- Lavage
-
Cleveland, Ohio
- +1 more
Sep 7, 2022
High-Risk Breast Duct Epithelium
Completed
- Breast Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 8, 2023
Ductal Lavage in Non-lactating Female Women With Mastitis
Completed
- Mastitis
- Ductal lavage therapy
-
Guangzhou, Guangdong, ChinaSun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
Aug 21, 2019
Women at High Genetic Risk of Breast Cancer: Annual Follow-Up
Completed
- Breast Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in Odense
Recruiting
- Pancreatic Cancer
- Pancreatic Adenocarcinoma
-
Odense, DenmarkOdense University Hospital
Jun 5, 2022
Women at High Genetic Risk of Breast Cancer: Menstrual Cycle
Completed
- Breast Cancer
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 24, 2020
Atypical Ductal Hyperplasia, Ductal Carcinoma in Situ Trial in Milan (Vacuum-assisted excisional biopsy)
Recruiting
- Atypical Ductal Hyperplasia
- Ductal Carcinoma in Situ
- Vacuum-assisted excisional biopsy
-
Milan, ItalyBreast Imaging Division, Radiology Department, IEO European Inst
Jun 27, 2023
Nipple Discharge Trial in Wuhan (contrast-enhanced spectral mammography)
Recruiting
- Nipple Discharge
- contrast-enhanced spectral mammography
-
Wuhan, Hubei, ChinaUnion Hospital of Tongji Medical College of Huazhong University
Sep 11, 2023
Idiopathic Granulomatous Mastitis Trial in Adana (Intralesional steroid administration, Intraoperative cavity steroid
Recruiting
- Idiopathic Granulomatous Mastitis
- Intralesional steroid administration
- Intraoperative cavity steroid administration
-
Adana, Yuregir, TurkeyBaskent University Adana Teaching Hospital
May 3, 2022
Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination
Not yet recruiting
- Salivary Gland Cancer
- vedicitumomab (Edisil, RC48)
- +3 more
- (no location specified)
Jun 9, 2023
Infections in Lung Transplantation
Recruiting
- Lung Transplant Infection
- +4 more
- BioFire Pneumonia Panel Plus
-
Milano, ItalyIrccs Fondazione Ca' Granda Policlinico Di Milano
Jul 17, 2023
Knee Trial in Barcelona (Bone lavage previous to cementation)
Active, not recruiting
- Knee
- Bone lavage previous to cementation
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Sep 4, 2023
Disorder of Pleura and Pleural Cavity Trial (medical thoracoscope, Forceps biopsy and pleural brush histopathology, pleural
Not yet recruiting
- Disorder of Pleura and Pleural Cavity
- medical thoracoscope
- +2 more
- (no location specified)
Sep 27, 2023
Detecting Epigenetic Imprinting Alterations in Bronchoalveolar
Recruiting
- Lung Cancer
- Quantitative Chromogenic Imprinted Gene in situ Hybridization (QCIGISH)
-
Nanjing, Jiangsu, China
- +2 more
Jan 29, 2023
Pancreatic Fistula, Pancreaticoduodenal; Fistula Trial in Hangzhou (Peritoneal lavage)
Not yet recruiting
- Pancreatic Fistula
- Pancreaticoduodenal; Fistula
- Peritoneal lavage
-
Hangzhou, Zhejiang, ChinaThe second affiliated hospital of Zhejiang University School of
Dec 18, 2022
Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of
Completed
- Pancreas Cancer
- (no location specified)
Jul 15, 2023
Pancreatic Ductal Adenocarcinoma Trial in Toronto (Durvalumab, Oleclumab)
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Sep 22, 2023
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Woodville South, Melbourne, Subiaco (CEND-1, Nab-paclitaxel,
Completed
- Pancreatic Cancer
- Pancreatic Ductal Adenocarcinoma
- CEND-1
- +2 more
-
Woodville South, South Australia, Australia
- +2 more
Oct 26, 2022
A Combination of AKR1B10 and CA19-9 Improves Diagnosis of PDAC
Recruiting
- Pancreatic Ductal Adenocarcinoma
-
Shanghai, Shanghai, China
- +2 more
Jul 13, 2022
PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)
Not yet recruiting
- PDAC - Pancreatic Ductal Adenocarcinoma
- Combination of sitagliptin+ gemcitabine + nab-paclitaxel
- (no location specified)
Jul 9, 2023
Minimal Residual Disease Using Multi-omics Approach
Not yet recruiting
- Pancreatic Ductal Adenocarcinoma
- Blood collection and Pancreatic ductal adenocarcinoma minimal residual disease detection test
-
Shanghai, ChinaDepartment of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Nov 29, 2023
Ductal Carcinoma in Situ Trial in Durham (Decision Support Tool with Active Monitoring, Decision Support Tool without Active
Completed
- Ductal Carcinoma in Situ
- Decision Support Tool with Active Monitoring
- Decision Support Tool without Active Monitoring
-
Durham, North CarolinaDuke Mammography Clinic
Jan 4, 2023
Breast Cancer Trial in Nice (Metal wire, Radioactive Iodine Seed)
Active, not recruiting
- Breast Cancer
- Metal wire
- Radioactive Iodine Seed
-
Nice, FranceCentre Antoine LACASSAGNE
Jan 19, 2023